What are the causes of hypercalcemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Hypercalcemia

The two most common causes of hypercalcemia are primary hyperparathyroidism (PHPT) and malignancy, accounting for approximately 90% of all cases 1. The diagnostic approach hinges on measuring serum PTH levels to distinguish PTH-dependent from PTH-independent etiologies 2.

Algorithmic Approach Based on PTH Levels

Hypercalcemia with Elevated or Normal PTH (PTH-Dependent)

Primary hyperparathyroidism is the predominant cause when PTH is elevated or inappropriately normal in the setting of hypercalcemia 1. This represents the most common etiology in outpatient settings, affecting approximately 1% of the population 1.

  • Primary hyperparathyroidism (PHPT): Most frequent cause overall, characterized by autonomous PTH secretion from parathyroid adenoma, hyperplasia, or rarely carcinoma
  • Familial hypocalciuric hypercalcemia (FHH): Genetic disorder due to inactivating mutations in CASR, GNA11, or AP2S1 genes, presenting with hypercalcemia and inappropriately normal or elevated PTH 2
  • Parathyroid carcinoma: Rare malignant cause requiring combined treatment with calcimimetics and antiresorptive agents 3

Critical pitfall: FHH can be mistaken for PHPT. The key distinguishing feature is that FHH patients have normal calciuria (not truly "hypocalciuric"), though this overlap makes genetic testing essential when suspected 2, 4.

Hypercalcemia with Suppressed or Low PTH (PTH-Independent)

When PTH is suppressed (<20 pg/mL), six main categories must be considered: malignant, granulomatous, genetic, immobilization-related, endocrine, or drug-induced 2.

Malignancy-Related Causes

Malignancy is the leading cause of hypercalcemia in hospitalized patients 1. Two distinct mechanisms exist:

  • Humoral hypercalcemia of malignancy: PTHrP secretion by solid tumors (epidermoid, neuroendocrine), causing hypercalcemia with hypophosphatemia due to proximal tubular effects 2
  • Local osteolytic hypercalcemia: Direct bone destruction from metastases (breast cancer) or myeloma, typically associated with hyperphosphatemia 2

The phosphate level differentiates these mechanisms: hypophosphatemia suggests PTHrP-mediated disease, while hyperphosphatemia indicates osteolytic metastases 2.

Vitamin D-Related Causes

Hypervitaminosis D induces hypercalcemia through three mechanisms 2:

  • Excessive supplementation: Increasingly common with overzealous vitamin D replacement 5
  • Granulomatous production: Unregulated calcitriol production by macrophages in sarcoidosis, tuberculosis, lymphoma, or pneumocystosis via extra-renal 1-alpha-hydroxylase 2
  • Genetic catabolism defects: CYP24A1 gene variants causing childhood idiopathic hypercalcemia type 1 with impaired vitamin D breakdown 2

Important note: Vitamin D toxicity was the second most common cause of hypercalcemia (24.8%) in one recent series, highlighting its emerging importance 5.

Genetic Causes (PTH-Independent)

Multiple rare genetic syndromes cause hypercalcemia with suppressed PTH 2:

  • Williams-Beuren syndrome: Chromosome 7 microdeletion causing infantile hypercalcemia (15% of cases), resolving by age 4, with mental retardation and cardiovascular abnormalities 2
  • Jansen's metaphyseal chondrodysplasia: Activating PTH1R gene variants causing hypercalcemia between 1 month and 10 years of age 2
  • Mahvash syndrome: Glucagon receptor (GCGR) gene variants 2
  • Hypophosphatasia: ALPL gene mutation with hypercalcemia, hyperphosphatemia, and low alkaline phosphatase 2
  • Congenital lactose intolerance: Lactase/iso-maltase deficiency with increased intestinal calcium absorption 2

Immobilization Hypercalcemia

Immobilization causes hypercalcemia through reduced mechanical stimulation of osteoblasts, increasing sclerostin and favoring osteoclastic resorption 2. This occurs:

  • In young adults 4-6 weeks after spinal cord trauma
  • In elderly poly-pathological patients weeks to months after immobilization onset 2

Endocrine Causes

Several endocrinopathies induce hypercalcemia with suppressed PTH 2:

  • Hyperthyroidism: Direct thyroid hormone action on bone resorption
  • Acute adrenal insufficiency: Hypercalcemia (typically <3 mmol/L) from dehydration and metabolic acidosis
  • Pheochromocytoma: Direct catecholamine effects on bone or PTHrP secretion
  • Acromegaly: Increased calcitriol production, occasionally causing hypercalcemic tendency

Other Important Causes

  • Cirrhosis: Hypercalcemia without increased PTH or vitamin D, associated with increased mortality, likely from inflammatory cytokines and prostaglandins 2
  • Medications: Thiazide diuretics, lithium, calcium supplements, vitamin A, denosumab discontinuation 1, 6
  • Milk-alkali syndrome: Excessive calcium and alkali intake 7

Essential Diagnostic Workup

Before attributing hypercalcemia to any specific cause, rule out confounding factors 2, 4:

  • Vitamin D deficiency: Measure 25-OH vitamin D
  • Renal insufficiency: Calculate eGFR
  • Malabsorption: Screen for inflammatory bowel disease, celiac disease, bariatric surgery history
  • Dietary factors: Assess calcium intake
  • Medications: Review thiazides, lithium, bisphosphonates, denosumab, corticosteroids, excessive vitamin D/calcium supplementation

These factors can mask or induce hypercalcemia and must be addressed before definitive diagnosis 2, 4.

Clinical Severity Classification

Hypercalcemia severity determines urgency of intervention 1:

  • Mild: Total calcium <12 mg/dL (<3 mmol/L) - usually asymptomatic, may have fatigue and constipation in 20%
  • Moderate: 12-14 mg/dL (3-3.5 mmol/L)
  • Severe: >14 mg/dL (>3.5 mmol/L) - causes nausea, vomiting, dehydration, confusion, somnolence, coma

Symptom severity relates to both absolute calcium level and rapidity of rise 1.

References

Research

Hypercalcemia: A Review.

JAMA, 2022

Research

[Hypercalcemia: a practical review].

Revue medicale suisse, 2024

Research

Rare Causes of Hypercalcemia.

Endocrinology and metabolism clinics of North America, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.